Radiofrequency Splanchnic Denervation Versus Retrocrural Neurolytic Celiac Block for Pancreatic Cancer Pain

For Patients With Pancreatic Cancer Pain, Does Radiofrequency Splanchnic Denervation Isprovide a Similar Analgesia as Neurolytic Celiac Block

Status

UNKNOWN

Phases

Study type

Interventional

Source

ClinicalTrials.gov

Registry ID

NCT03886298

Enrollment

Registered

2019-03-22

Start date

2019-04-10

Completion date

2020-06-10

Last updated

2019-07-08

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Chronic Pain

Brief summary

The investigators will evaluate the analgesic efficacy of radiofrequency splanchnic nerve denervation versus neurolytic retrocrural celiac denervation for patients with abdominal pain due to cancer pancreas

Interventions

PROCEDUREradiofrequency splanchnic denervation

the authors will denervate the splanchnic nerves via radiofrequency

PROCEDUREretrocrural celiac denervation

the authors will denervate the splanchnic nerves in the retrocrural space via injection of alcohol

Study design

Allocation

RANDOMIZED

Intervention model

PARALLEL

Primary purpose

TREATMENT

Masking

SINGLE (Outcomes Assessor)

Eligibility

Sex/Gender

ALL

Age

16 Years to 90 Years

Healthy volunteers

Inclusion criteria

* patients with abdominal pain due to cancer pancreas

Exclusion criteria

* coagulopathy * infection at site of the procedure

Design outcomes

Primary

Measure	Time frame	Description
the percentage of patients that gain more than 50% reduction of their pain on VAS pain score	6 months postoperatively	VAS pain scale is a tool for measurement of pain intensity scored from 0 to 10 in which 0 + no pain and 10 + the worst pain immaginable

Countries

Egypt

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026